eubiologics

Á¦Ç° ¹× ¿¬±¸°³¹ß

Development and supply of safe and effective vaccine for global public health

¹é½Å

À¯ºñÄÝ¢ç-Ç÷¯½º

À¯ºñÄÝ¢ç-Ç÷¯½º´Â ¼¼°è ÃÖÃÊÀÇ Çöó½ºÆ½ Æ©ºêÇü ¹é½ÅÀ̸ç, ±âÁ¸ À¯ºñÄÝ Á¦Ç°º¸´Ù º¸°ü ¹× ¼ö¼Û¿¡ ¿ëÀÌÇÏ°í Åõ¿©°¡ °£ÆíÇÑ ÀåÁ¡ÀÌ ÀÖ½À´Ï´Ù. Æ©ºê¸¦ Èçµé¾î Áï½Ã Åõ¿©ÇÏ´Â °£ÆíÇÑ º¹¿ë¹ý°ú Àú·ÅÇÑ °¡°ÝÀ¸·Î Àü ¼¼°è °ø°ø¹é½Å ½ÃÀå¿¡¼­ µ¶Á¡ °ø±ÞµÇ°í ÀÖ½À´Ï´Ù. À¯ºñÄÝ¢ç-Ç÷¯½º´Â ¼¼°è ¼¼¹ø°·Î WHO-PQ ½ÂÀÎ µÈ Á¦Ç°À¸·Î, Çöó½ºÆ½ Æ©ºê Á¦ÇüÀ¸·Î 2017³â 8¿ù WHO-PQ¸¦ ¹Þ¾Ò½À´Ï´Ù.
Á¦Ç°¸í À¯ºñÄÝ¢ç-Ç÷¯½º(°æ±¸¿ëºÒÈ°È­ÄÝ·¹¶ó¹é½Å)
Á¦Ç°±¸ºÐ Àü¹®ÀǾàÇ°(±º¼ö¿ë,°ü¼ö¿ë)
¿ë¹ý¿ë·® 2ÁÖ °£°ÝÀ¸·Î 2ȸ °æ±¸ Åõ¿©
Á¦Ç°¼º»ó ºÒÈ°È­½ÃŲ ÄÝ·¹¶ó±ÕÀ» ÇÔÀ¯Çϴ Ȳ»ö ¶Ç´Â ¹ÌȲ»öÀ» ¶ì´Â ŹÇÑ ¿ë¾×ÀÌ ÃæÀüµÈ Çöó½ºÆ½ Æ©ºê
È¿´É/È¿°ú 1¼¼ ÀÌ»óÀÇ ¼Ò¾Æ, û¼Ò³â ¹× ¼ºÀο¡¼­ Vibrio cholerae serogroup O1¿¡ ÀÇÇØ ¹ßº´µÇ´Â ÄÝ·¹¶óÀÇ ¿¹¹æ.(´Ü, Vibrio cholerae serogroup O139¿¡ ´ëÇÑ È¿´ÉÀº È®ÀεÇÁö ¾Ê¾ÒÀ½.)
¼Ò°³ÀÚ·á ´Ù¿î·Îµå ¼³¸í¼­ ´Ù¿î·Îµå
Euvichol-Plus

Á¦Ç°¼ººÐ

Vaccine strain Quantity
V. cholerae O1 Inaba Cairo 48 (H) 300 L.E.U*
V. cholerae O1 Inaba Phil 6973 El Tor (F) 600 L.E.U
V. cholerae O1 Ogawa Cairo 50 (F) 300 L.E.U
V. cholerae O1 Ogawa Cairo 50(H) 300 L.E.U
V. cholerae O139 4260B (F) 600 L.E.U

H:Heat inactivated F:Formalin inactivated

* LEU : Lipopolysaccharide ELISA Units

Á¦Ç°Á¤º¸

¿ë¹ý/¿ë·® ÀúÀå¹æ¹ý À¯È¿±â°£
2ÁÖ °£°ÝÀ¸·Î 2ȸ °æ±¸ Åõ¿© 2¡É ~ 8¡É ³ÃÀ庸°ü Á¦Á¶ÀϷκÎÅÍ 24°³¿ù